发明名称 Methods and compositions for treating viral infections
摘要 The disclosure demonstrates the inhibition of replication of human cytomegalovirus (HCMV) in cultured human embryo skin muscle cells by two separate subclasses of direct-acting smooth muscle relaxing agents. These two subclasses are characterized mechanistically as calcium influx blockers (or calcium channel blockers) and cyclic nucleotide modulators. More specifically, the class of calcium influx blockers is exemplified by the drugs verapamil (and methoxyverapamil), nifedipine (the prototype drug of 1,4 dihydropyridines), and diltiazem. The class of cyclic nucleotide modulators is exemplified by the drugs isobutylmethylxanthine, papaverine (and its synthetic analog dioxyline), forskolin, and sodium nitroprusside. All of these agents inhibit replication of HCMV and HSV.
申请公布号 US4782065(A) 申请公布日期 1988.11.01
申请号 US19870002981 申请日期 1987.01.13
申请人 BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 发明人 ALBRECHT, THOMAS;STEINSLAND, ODD S.
分类号 A61K31/275;A61K31/35;A61K31/44;A61K31/485;A61K31/52;A61K31/55;A61K33/26;(IPC1-7):A61K31/44;A61K31/47 主分类号 A61K31/275
代理机构 代理人
主权项
地址